Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strategic Research Institute (SRI) was a prominent provider of business-to-business conferences and strategic intelligence, with a significant focus on the life sciences, biotechnology, and pharmaceutical sectors. Founded in the early 1990s, the company became well-known for hosting high-level industry summits that brought together biotech executives, pharmaceutical leaders, and institutional investors to discuss drug discovery, development strategies, and market trends. SRI's portfolio included specialized events such as the 'Drug Discovery and Development of Oncology Therapeutics' and various 'Biotech Strategy' summits. The company played a key role in facilitating industry partnerships and investment flows during the biotech boom of the late 1990s and early 2000s. In 2006, Strategic Research Institute was acquired by the Institute for International Research (IIR), which was subsequently integrated into the Informa group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strategic Research Institute.